Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2002-07-30
2008-12-23
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S184100, C424S234100, C435S440000, C435S471000, C435S477000, C536S023100, C536S023700
Reexamination Certificate
active
07468190
ABSTRACT:
The construction of a mutant in the phoP gene by means of homologous recombination from a clinically isolatedMycobacterium tuberculosisreduces the virulence thereof in mouse bone marrow macrophage. Moreover, the phoP mutant reduces the virulence thereof in the experimental mouse model. Said phoP mutant can persist without being eliminated both in the macrophage and in the mouse. Mice inoculated with the phoP mutant are protected againstM. tuberculosisinfection. The use of mutants of mycobacteria in which the phoP gene or the genes regulated by phoP have been inactivated are candidates for vaccines against human and animal tuberculosis as well as possible recombinant vaccines against other pathogens.
REFERENCES:
patent: 5424065 (1995-06-01), Curtiss et al.
patent: WO 9011687 (1990-10-01), None
patent: WO 9502048 (1995-01-01), None
patent: WO 9720033 (1997-06-01), None
Wren, B.W., et al. Degenerate PCR primers for the amplification of fragments from genes encoding response regulators from a range of pathogenic bacteria. FEMS Microbiology Letters, ((:287-292, 1992.
Perez, E et al. “An essential role forpho PinMycobacterium tuberculosisvirulence” Molecular Microbiology 2001, vol. 41, No. 1, pàginas 179-187. Todo el documento.
Zahrt, T.C. et al. “An essential two component signal transduction system inMycobacterium tuberculosis” Journal of Bacteriology, 2000, vol. 182, No. 13, pàginas 3832-3838. Todo el documento.
Zahrt, T.C. et al. “Elements of signal transduction inMycobacterium tuberculosis: in vitro phosphrylation and in vivo expression of the response regulator MtrA” Journal of Bacteriology, 1996, vol. 178, No.11, pàginas 3314-3321. Todo el documento.
Zahrt, T.C. et al. “Mycobacterium tuberculosissignal transduction system required for persistent infectious”. PNAS, 2001, vol. 98, No. 22 pàginas 12706-12711. Todo el documento.
Giquel Brigitte
Herran Esther Perez
Montaines Carlos Martin
Crowell & Moring LLP
Swartz Rodney P.
Universidad De Zaragoza
LandOfFree
Reduction in the virulence of Mycobacterium tuberculosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduction in the virulence of Mycobacterium tuberculosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction in the virulence of Mycobacterium tuberculosis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4029568